Hong Kong Pharma Files 6-K for March 2025
Ticker: HKPD · Form: 6-K · Filed: Mar 28, 2025 · CIK: 2007702
Sentiment: neutral
Topics: reporting, 6-K, foreign-private-issuer
TL;DR
HK Pharma filed a 6-K for March, confirming 20-F annual reports.
AI Summary
Hong Kong Pharma Digital Technology Holdings Limited filed a Form 6-K on March 28, 2025, reporting for the month of March 2025. The company, incorporated in E9, is a wholesale distributor of proprietary drugs and sundries. The filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulators regarding the company's reporting status and business activities.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that does not appear to contain significant new financial or operational information.
Key Players & Entities
- Hong Kong Pharma Digital Technology Holdings Limited (company) — Registrant
- March 2025 (date) — Reporting period
- 20250328 (date) — Filing date
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Filing type
- Lap Sun Wong (person) — Signatory
FAQ
What is the primary business of Hong Kong Pharma Digital Technology Holdings Limited?
The company is involved in the wholesale of drugs, proprietaries, and druggists' sundries, as indicated by its SIC code 5122.
What is the filing date of this Form 6-K?
The filing date is March 28, 2025.
Which form does the company use for its annual reports?
The company indicates it files annual reports under cover of Form 20-F.
Where is the principal executive office of the company located?
The principal executive offices are located at Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong.
Who signed this Form 6-K on behalf of the company?
The form was signed by Lap Sun Wong.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 28, 2025 by Lap Sun Wong regarding Hong Kong Pharma Digital Technology Holdings Ltd (HKPD).